In further experiments, we found that Sox2 can promote the proliferation, migration, and invasion of endometrial cancer non-stem cells and ECSCs, reduce apoptosis and cell cycle arrest, enhance cell self-renewal ability and chemotherapeutic drug resistance, and enhance stem cell marker expression. The gene discussed is SOX2; the disease is endometrial cancer.